Day: January 30, 2024

Management to Provide Business & Financial Update on Key Operational Initiatives EAST RUTHERFORD, NJ, Jan. 30, 2024 (GLOBE NEWSWIRE) — Mama’s Creations, Inc. (NASDAQ: MAMA), a leading national marketer and manufacturer of fresh Deli prepared foods, today announced that management will host a virtual investor day presentation at 1:00 p.m. Eastern time on Tuesday, February 13, 2024. Mama’s Creations Chairman & Chief Executive Officer Adam L. Michaels, Chief Financial Officer Anthony Gruber and Chief Marketing Officer Lauren Sella will provide a corporate update, discuss management’s go-forward strategy and conclude with a question-and-answer session. The full presentation will be available using the webcast link below. Virtual Investor Day PresentationDate: Tuesday, February 13, 2024Time: 1:00 p.m. Eastern timeToll...

Program Secured with Channel Partner and National Wireless Network Operator for a Large U.S. Government Agency’s 4,000 Locations BATAVIA, Ill., Jan. 30, 2024 (GLOBE NEWSWIRE) — High Wire Networks, Inc. (OTCQB: HWNI), a leading global provider of managed cybersecurity and technology enablement, has secured through one of its premier channel partners a major pilot project with a national wireless network operator for a large U.S. government agency. The project represents the initial phase of the operator’s $2.4 billion network modernization program for the agency’s 4,000 locations across the U.S. which is planned to be implemented over the next 10 years. The project has begun this week with High Wire conducting a network survey at its initially assigned secure locations. This will be followed by network upgrades at these locations,...

New Application of OSS High Performance Computing Technology to Power Race Analytics for Andretti Using Orquestra®, Zapata AI’s Industrial Generative AI Platform for the Cloud and EdgeOSS Gen 4 PCIe® SDS-3U GPU-Accelerated ServerOSS Gen 4 PCIe® SDS-3U GPU-Accelerated ServerESCONDIDO, Calif., and INDIANAPOLIS, Jan. 30, 2024 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (Nasdaq: OSS) has shipped to legendary motorsport champion, Andretti Global, its first AI Transportable compute system for the motorsport industry. An OSS SDS-3U GPU-accelerated server will power advanced AI race analytics for Andretti using Zapata AI’s Industrial Generative AI platform for the cloud and edge, Orquestra. The solution represents a new application of OSS technology and the company’s first foray into the $5.1 billion motorsport industry. Today’s...

BERKELEY HEIGHTS, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced updates related to its business and anticipated launch of DefenCath®. Recent Updates:On January 25, 2024 the Center for Medicare & Medicaid Services (CMS) notified CorMedix that the agency has determined DefenCath will be eligible for reimbursement in accordance with the ESRD PPS. As such, CorMedix is entitled to submit an application for a Transitional Drug Add-On Payment (TDAPA) which currently allows for five years of additional payment reimbursement to outpatient providers. CorMedix submitted its TDAPA application on January 26th after receiving the...

LAKEWOOD, NJ, Jan. 30, 2024 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI; RELIW) (“Reliance” or the “Company”), today announced that it has added the RELI Exchange Client Referral Portal (CRP) into its proprietary InsurTech platform, RELI Exchange. Ezra Beyman, CEO of Reliance, stated, “Since its inception, RELI Exchange has been consistently evolving to offer better functionality and provide greater benefits to our existing and prospective agency partners. We recently launched the proprietary RELI Exchange CRP, designed to help agency partners establish and strengthen connections with a range of professional service providers, including but not limited to, real estate agents, car dealerships, and mortgage brokers. These professionals frequently interact with clients in need of insurance products. Using this...

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and ApplicationSI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and ApplicationSANTA CLARA, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announces FDA 510(k) premarket clearance of the iFuse Bedrock Granite® Implant System (Granite) in a smaller (9.5 mm) diameter with both an expanded indication in pediatric patients and an expanded application that includes use in the S1 trajectory. When placed across the SI joint, the Granite implant provides sacroiliac fusion and sacropelvic...

ATHENS, Greece, Jan. 30, 2024 (GLOBE NEWSWIRE) — Seanergy Maritime Holdings Corp. (the “Company” or “Seanergy”) (NASDAQ: SHIP), through its wholly-owned subsidiary Seanergy Shipmanagement Corp., is the first Greek-based shipping company to accomplish a strategic partnership in the European Union Funded SAFeCRAFT Project Consortium (“Safecraft”), a breakthrough initiative concerning the utilization of alternative fuels. Safecraft aims to demonstrate the safety and viability of Sustainable Alternative Fuels (SAFs) in seaborne transportation, accelerating the adoption of SAFs technologies. Seanergy will provide one of its existing, conventionally fueled Capesize vessels as the demonstrating vessel under Safecraft which will be retrofitted to utilize hydrogen (H2) as the main energy source for electric power...

Customers identify in-house control, project flexibility, productivity, and cost reductions as key business benefits of fingerprint sweat-based drug testing Construction and manufacturing firms replace traditional urine and oral fluid drug tests with more hygienic and dignified Intelligent Fingerprinting Drug Screening System – disrupting workplace testing market NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today reported on the key operational benefits that customers are experiencing following deployment of the Intelligent Fingerprinting Drug Screening System to support workplace drug testing. Customers across critical sectors such as construction, manufacturing...